Lapatinib, 2 g

Lapatinib falls within a group of substances characterized by consistent performance as tyrosine kinase inhibitors. Its molecular formula is C26H28N6O5, with a molecular weight of 484.5 g/mol. This compound is a quinazoline derivative, known for its ability to bind to the ATP binding site of certain protein kinases, thereby inhibiting their activity. Lapatinib is supplied as a white crystalline powder with a purity of 99% and a pack size of 2 grams. It is commonly used in research related to cancer therapy, particularly in the treatment of breast cancer. Additionally, it has been shown to exhibit potent antiproliferative effects against various tumor cell lines.

• CAS Number: 231277-92-2